Corrigendum to “DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer” [Canc. Lett. 501 224–233]

Publication date: 1 June 2023Source: Cancer Letters, Volume 563Author(s): Dotan Moskovich, Adi Alfandari, Yael Finkelshtein, Avivit Weisz, Aviva Katzav, Debora Kidron, Evgeny Edelstein, Daniel Veroslavski, Ruth Perets, Nissim Arbib, Yfat Kadan, Ami Fis…